Baatarkhuu O, Lee J S, Amarsanaa J, Kim D Y, Ahn S H, Naranzul N, Enkhtuya D, Choijamts N, Batbayar P, Otgonbayar R, Saruul B-U, Gantuul C, Gegeebadrakh B, Tuvshinbayar N, Badamsuren D, Ulzmaa G, Otgonbold J, Han K-H
Ledipasvir/sofosbuvir (LDV/SOF) shows high efficacy and safety in patients with genotype 1-hepatitis C virus (HCV). We aimed to investigate the efficacy and safety of LDV/SOF in real-world Mongolian patients.
